Latent Tuberculosis Infection Among Immigrant and Refugee Children Arriving in the United States: 2010

Journal of Immigrant and Minority Health

Volumn 18, Issue 5, 2016, Pages 966-970

  Taylor, Eboni M ^a,b   Painter, John ^a,b   Posey, Drew L ^a,b   Zhou, Weigong ^a,b   Shetty, Sharmila ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b U S PUBLIC HEALTH SERVICE   (United States)

Author keywords

Interferon gamma release assay; Migrants; Pediatric; Tuberculin skin test

Indexed keywords

ADOLESCENT; CHILD; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; HUMAN; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MALE; MIGRANT; PRESCHOOL CHILD; REFUGEE; TUBERCULIN TEST; UNITED STATES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; INCIDENCE; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; REFUGEES; TUBERCULIN TEST; UNITED STATES;

EID: 84941343570     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-015-0273-2     Document Type: Article

References (20)

1. Miramontes R, Pratt R, Price SF, Jeffries C, Navin TR, Oramasionwu GE. Trends in tuberculosis—United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(11):181–5.
2. Al-Orainey IO. Diagnosis of latent tuberculosis: can we do better? Ann Thorac Med. 2009;4(1):5.
3. Linas BP, Wong AY, Freedberg KA, Horsburgh CR. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2011;184(5):590–601.
4. Mazurek GH, Jereb JA, Vernon A, LoBue P, Goldberg S, Castro KG. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection, United States, 2010. MMWR Recomm Rep. 2010;59(RR05);1–25.
5. Rose DN. Benefits of screening for latent Mycobacterium tuberculosis infection. Arch Intern Med. 2000;160(10):1513.
6. Hill A, Becerra J, Castro K. Modelling tuberculosis trends in the USA. Epidemiol Infect. 2012;140(10):1862.
7. Centers for Disease Control and Prevention. CDC immigration requirements: technical instructions for tuberculosis screening and treatment using cultures and directly observed therapy. Atlanta, GA: US Department of Health and Human Services; 2009.
8. Cohn DL, O’Brien RJ, Geiter LJ, Gordin F, Hershfield E, Horsburgh C. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2000;49(6):1–54.
9. US Department of Homeland Security, C.a.B.P. TECS, arrival file: fiscal years 2010 to 2011. Washington: C.a.B.P. US Department of Homeland Security; 2012.
10. Centers for Disease Control and Prevention: Technical instructions implementation. 2011 February 5, 2013; (cited 2013 February 14). http://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/tuberculosis-implementation.html.
11. Centers for Disease Control and Prevention: Latent tuberculosis infection: a guide for primary health care providers 2010 November 24, 2010; (cited 2013 April 15). http://www.cdc.gov/tb/publications/ltbi/diagnosis.htm.
12. Hirsch-Moverman Y, Bethel J, Colson P, Franks J, El-Sadr W. Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience. Int J Tuberc Lung Dis. 2010;14(9):1104–11.
13. Coly A, Morisky D. Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles. Int J Tuberc Lung Dis. 2004;8(6):703–10.
14. LoBue PA, Moser KS. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med. 2003;168(4):443–7.
15. Young J, Edick T, Klee D, O’Connor ME. Successful treatment of pediatric latent tuberculosis infection in a community health center clinic. Pediatr Infect Dis J. 2012;31(9):e147–51.
16. Hovell MF, Sipan CL, Blumberg EJ, Hofstetter CR, Slymen D, Friedman L, Moser K, Kelley NJ, Vera AY. Increasing Latino adolescents’ adherence to treatment for latent tuberculosis infection: a controlled trial. Am J Public Health. 2003;93(11):1871–7.
17. Centers for Disease Control and Prevention: Guidelines for the U.S. domestic medical examination for newly arriving refugees. 2012 September 24, 1012; (cited 2013 April 15). http://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/domestic-guidelines.html.
18. Advisory Council for the Elimination of Tuberculosis (ACET). The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States. A Joint Statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 1996;45(RR-4):1–27.
19. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?[Review Article]. Int J Tuberc Lung Dis. 2006;10(11):1192–204.
20. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8(3):e1001012.